{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:08:07Z","timestamp":1775070487161,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jcv.2021.105014","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T12:33:37Z","timestamp":1635942817000},"page":"105014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS)"],"prefix":"10.1016","volume":"145","author":[{"given":"Tina","family":"Raine-Bennett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia C.","family":"Gage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Poitras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malini","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Varnado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Befano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2021.105014_bib0001","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"16","key":"10.1016\/j.jcv.2021.105014_bib0002","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jcv.2021.105014_bib0003","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Force","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2021.105014_bib0004","doi-asserted-by":"crossref","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines","volume":"17","author":"Katki","year":"2013","journal-title":"J. Low Genit. Tract Dis."},{"issue":"11","key":"10.1016\/j.jcv.2021.105014_bib0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/cncy.21463","article-title":"The low risk of precancer after a screening result of human papillomavirus-negative\/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management","volume":"122","author":"Gage","year":"2014","journal-title":"Cancer Cytopathol."},{"issue":"3","key":"10.1016\/j.jcv.2021.105014_bib0006","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2015.06.040","article-title":"A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results","volume":"138","author":"Schiffman","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.jcv.2021.105014_bib0007","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1002\/ijc.29119","article-title":"HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer","volume":"136","author":"Mirabello","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"22","key":"10.1016\/j.jcv.2021.105014_bib0008","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/jnci\/djs425","article-title":"Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3","volume":"104","author":"Wentzensen","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.jcv.2021.105014_bib0009","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2015.06.040","article-title":"A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results","volume":"138","author":"Schiffman","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.jcv.2021.105014_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw100","article-title":"HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women","volume":"108","author":"Mirabello","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.jcv.2021.105014_bib0011","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2017.08.001","article-title":"HPV16 E7 genetic conservation is critical to carcinogenesis","volume":"170","author":"Mirabello","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2021.105014_bib0012","unstructured":"Gordon N.P. Similarity of adult kaiser permanente members to the adult population in Kaiser permanente's northern California service area: comparisons based on the 2017\/2018 cycle of the California health interview survey. Kaiser Permanente Northern California. November 8, 2020 (https:\/\/divisionofresearch.kaiserpermanente.org\/projects\/memberhealthsurvey\/SiteCollectionDocuments\/compare_kp_ncal_chis2017-18.pdf)."},{"issue":"1\u20132","key":"10.1016\/j.jcv.2021.105014_bib0013","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jviromet.2007.06.001","article-title":"Human papillomavirus genotyping after denaturation of specimens for hybrid capture 2 testing: feasibility study for the HPV persistence and progression cohort","volume":"146","author":"LaMere","year":"2007","journal-title":"J. Virol. Methods"},{"issue":"2","key":"10.1016\/j.jcv.2021.105014_bib0014","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jviromet.2008.05.017","article-title":"Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotyping","volume":"151","author":"LaMere","year":"2008","journal-title":"J. Virol. Methods"},{"issue":"2","key":"10.1016\/j.jcv.2021.105014_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/v10020080","article-title":"The intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcinogenesis","volume":"10","author":"Mirabello","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jcv.2021.105014_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2015.09.014","article-title":"VALGENT: a protocol for clinical validation of human papillomavirus assays","volume":"76","author":"Arbyn","year":"2016","journal-title":"J. Clin. Virol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665322100281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665322100281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:16:00Z","timestamp":1761362160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138665322100281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":16,"alternative-id":["S138665322100281X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2021.105014","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS)","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2021.105014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105014"}}